282 related articles for article (PubMed ID: 19520121)
1. The unconditioned fear produced by morphine withdrawal is regulated by mu- and kappa-opioid receptors in the midbrain tectum.
De Ross J; Avila MA; Ruggiero RN; Nobre MJ; Brandão ML; Castilho VM
Behav Brain Res; 2009 Dec; 204(1):140-6. PubMed ID: 19520121
[TBL] [Abstract][Full Text] [Related]
2. Neuroanatomical and neuropharmacological study of opioid pathways in the mesencephalic tectum: effect of mu(1)- and kappa-opioid receptor blockade on escape behavior induced by electrical stimulation of the inferior colliculus.
Osaki MY; Castellan-Baldan L; Calvo F; Carvalho AD; Felippotti TT; de Oliveira R; Ubiali WA; Paschoalin-Maurin T; Elias-Filho DH; Motta V; da Silva LA; Coimbra NC
Brain Res; 2003 Dec; 992(2):179-92. PubMed ID: 14625057
[TBL] [Abstract][Full Text] [Related]
3. µ- and κ-Opioid receptor activation in the dorsal periaqueductal grey matter differentially modulates panic-like behaviours induced by electrical and chemical stimulation of the inferior colliculus.
Twardowschy A; Coimbra NC
Brain Res; 2015 Feb; 1597():168-79. PubMed ID: 25485771
[TBL] [Abstract][Full Text] [Related]
4. Mu-opioid and CB1 cannabinoid receptors of the dorsal periaqueductal gray interplay in the regulation of fear response, but not antinociception.
Godoi MM; Junior HZ; da Cunha JM; Zanoveli JM
Pharmacol Biochem Behav; 2020 Jul; 194():172938. PubMed ID: 32376258
[TBL] [Abstract][Full Text] [Related]
5. A comparative study of the effects of morphine in the dorsal periaqueductal gray and nucleus accumbens of rats submitted to the elevated plus-maze test.
Anseloni VC; Coimbra NC; Morato S; Brandão ML
Exp Brain Res; 1999 Nov; 129(2):260-8. PubMed ID: 10591900
[TBL] [Abstract][Full Text] [Related]
6. Involvement of the midbrain tectum in the unconditioned fear promoted by morphine withdrawal.
Avila MA; Ruggiero RN; Cabral A; Brandão ML; Nobre MJ; Castilho VM
Eur J Pharmacol; 2008 Aug; 590(1-3):217-23. PubMed ID: 18577378
[TBL] [Abstract][Full Text] [Related]
7. Participation of dorsal periaqueductal gray 5-HT1A receptors in the panicolytic-like effect of the κ-opioid receptor antagonist Nor-BNI.
Maraschin JC; Almeida CB; Rangel MP; Roncon CM; Sestile CC; Zangrossi H; Graeff FG; Audi EA
Behav Brain Res; 2017 Jun; 327():75-82. PubMed ID: 28347824
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological evidence for the mediation of the panicolytic effect of fluoxetine by dorsal periaqueductal gray matter μ-opioid receptors.
Roncon CM; Almada RC; Maraschin JC; Audi EA; Zangrossi H; Graeff FG; Coimbra NC
Neuropharmacology; 2015 Dec; 99():620-6. PubMed ID: 26320545
[TBL] [Abstract][Full Text] [Related]
9. Characterisation of opioid receptors involved in modulating circular and longitudinal muscle contraction in the rat ileum.
Gray AC; White PJ; Coupar IM
Br J Pharmacol; 2005 Mar; 144(5):687-94. PubMed ID: 15678085
[TBL] [Abstract][Full Text] [Related]
10. Effects of microinjections of mu and kappa receptor agonists into the dorsal periaqueductal gray of rats submitted to the plus maze test.
Motta V; Penha K; Brandão ML
Psychopharmacology (Berl); 1995 Aug; 120(4):470-4. PubMed ID: 8539329
[TBL] [Abstract][Full Text] [Related]
11. GABA and opioid mechanisms of the central amygdala underlie the withdrawal-potentiated startle from acute morphine.
Cabral A; Ruggiero RN; Nobre MJ; Brandão ML; Castilho VM
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):334-44. PubMed ID: 19150477
[TBL] [Abstract][Full Text] [Related]
12. The role of nitric oxide in the development of opioid withdrawal induced by naloxone after acute treatment with mu- and kappa-opioid receptor agonists.
Capasso A; Sorrentino L; Pinto A
Eur J Pharmacol; 1998 Oct; 359(2-3):127-31. PubMed ID: 9832382
[TBL] [Abstract][Full Text] [Related]
13. The benzodiazepine midazolam acts on the expression of the defensive behavior, but not on the processing of aversive information, produced by exposure to the elevated plus maze and electrical stimulations applied to the inferior colliculus of rats.
Saito VM; Brandão ML
Neuropharmacology; 2015 Jan; 88():180-6. PubMed ID: 25107589
[TBL] [Abstract][Full Text] [Related]
14. Positive allosteric modulation of the cannabinoid type-1 receptor (CB1R) in periaqueductal gray (PAG) antagonizes anti-nociceptive and cellular effects of a mu-opioid receptor agonist in morphine-withdrawn rats.
Datta U; Kelley LK; Middleton JW; Gilpin NW
Psychopharmacology (Berl); 2020 Dec; 237(12):3729-3739. PubMed ID: 32857187
[TBL] [Abstract][Full Text] [Related]
15. Conditioned antinociception and freezing using electrical stimulation of the dorsal periaqueductal gray or inferior colliculus as unconditioned stimulus are differentially regulated by 5-HT2A receptors in rats.
Castilho VM; Brandão ML
Psychopharmacology (Berl); 2001 May; 155(2):154-62. PubMed ID: 11401004
[TBL] [Abstract][Full Text] [Related]
16. Role of benzodiazepine and serotonergic mechanisms in conditioned freezing and antinociception using electrical stimulation of the dorsal periaqueductal gray as unconditioned stimulus in rats.
Castilho VM; Macedo CE; Brandão ML
Psychopharmacology (Berl); 2002 Dec; 165(1):77-85. PubMed ID: 12474121
[TBL] [Abstract][Full Text] [Related]
17. Impaired fear inhibitory properties of GABAA and μ opioid receptors of the dorsal periaqueductal grey in alcohol-withdrawn rats.
Silva LBC; Nobre MJ
Acta Neurobiol Exp (Wars); 2014; 74(1):54-66. PubMed ID: 24718044
[TBL] [Abstract][Full Text] [Related]
18. Neuroanatomical and psychopharmacological evidence for interaction between opioid and GABAergic neural pathways in the modulation of fear and defense elicited by electrical and chemical stimulation of the deep layers of the superior colliculus and dorsal periaqueductal gray matter.
Eichenberger GC; Ribeiro SJ; Osaki MY; Maruoka RY; Resende GC; Castellan-Baldan L; Corrêa SA; Da Silva LA; Coimbra NC
Neuropharmacology; 2002 Jan; 42(1):48-59. PubMed ID: 11750915
[TBL] [Abstract][Full Text] [Related]
19. Involvement of midbrain tectum neurokinin-mediated mechanisms in fear and anxiety.
Brenes JC; Broiz AC; Bassi GS; Schwarting RK; Brandão ML
Braz J Med Biol Res; 2012 Apr; 45(4):349-56. PubMed ID: 22392188
[TBL] [Abstract][Full Text] [Related]
20. Focal kappa-opioid receptor-mediated dependence and withdrawal in the nucleus paragigantocellularis.
Sinchaisuk S; Ho IK; Rockhold RW
Pharmacol Biochem Behav; 2002 Dec; 74(1):241-52. PubMed ID: 12376173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
